Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Social Networks
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC4356548/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC4356548/. The analysis below is for the second page.

Title[redir]:
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma - PMC
Description:
Up to 50% of patients with uveal melanoma (UM) develop metastatic disease with limited treatment options. The immunomodulating agent ipilimumab has shown an overall survival (OS) benefit in patients with cutaneous metastatic melanoma in two phase ...

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 6,398,900 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We don’t know how the website earns money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Ncbi.nlm.nih.gov could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

patients, ipilimumab, melanoma, metastatic, google, scholar, doi, pubmed, treatment, study, phase, uveal, months, pmc, data, survival, rate, median, trial, article, week, aes, free, disease, cancer, clinical, table, pdf, dose, number, alc, pretreated, treatmentnaïve, year, studies, received, tumor, activity, safety, mgkg, response, inhibitor, fig, doses, oncol, advanced, efficacy, criteria, results, death,

Topics {✒️}

c-met/vegfr2 inhibitor cabozantinib skin-related toxic effects—pruritus dana-farber cancer institute pmc beta search histone-deacetylase inhibitor vorinostat regulates t-cell activation weekly docosahexaenoic acid-paclitaxel helsinki/good clinical practice engineered pd-l1 antibody data availability statement immune-related response criteria anti-pd-l1 antibody protocol-specific treatment algorithms protocol-specific treatment guidelines immune-related gastrointestinal aes bristol-myers squibb supporting information files decog-mm-pal11-trial treatment-related death due including immune-related aes um remains ill-defined progression-free survival [google scholar] 12 [google scholar] 18 [google scholar] 24 [google scholar] 31 [google scholar] 38 long-term survival benefit /ii study evaluating phase iii trials drug-related death due data availability statements license information pmcid american joint committee skin cancer units phase ii trial supporting trend checklist evaluated 10mg/kg ipilimumab phase ii study supplementary materials included publisher site pdf anti-pd-1 antibody randomized clinical trial immune-related gastrointestinal spanish melanoma group multicentric randomized trial emerging toxicity profiles mek inhibitor trametinib protocol-specific guidelines immune checkpoint molecule

Social Networks {👍}(6)

External Links {🔗}(94)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

3.44s.